Kevin Dawson, MD
Dermatology · Honolulu, HINPI 1811959414
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,224 of the $15,832 with a category attached, or 83.5%. It is spread thinly across 23 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $5,312 and has fallen 59.3% since, to $2,160 in 2025.
Across 530 payments — averaging $29.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dermavant Sciences, Inc.$3K
- AbbVie$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Lilly USA, LLC$1K
- Novartis$1K
- Sanofi$942
- plus $6K from 17 others
What the payments were for
- Consulting fees$2,50016%
- Food & beverage$13,22484%
- Education$1081%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dermavant Sciences, Inc. | 7 | $2,847 |
| AbbVie | 96 | $2,201 |
| Regeneron Healthcare Solutions, Inc. | 34 | $1,381 |
| Lilly USA, LLC | 46 | $1,278 |
| Novartis | 39 | $1,190 |
| Sanofi | 34 | $942 |
| LEO Pharma Inc. | 51 | $818 |
| E.r. Squibb & Sons, L.L.C. | 28 | $785 |
| Sun Pharmaceutical Industries Inc. | 33 | $721 |
| UCB, Inc. | 19 | $652 |
| Amgen | 29 | $541 |
| Pfizer | 21 | $540 |
| Incyte Corporation | 18 | $501 |
| Galderma Laboratories, L.p. | 16 | $325 |
| Arcutis Biotherapeutics, Inc. | 19 | $268 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 19 | $242 |
| Johnson & Johnson | 8 | $197 |
| Dermira, Inc. | 3 | $161 |
| Genentech USA, Inc. | 6 | $137 |
| Organon | 1 | $31 |
| Biofrontera Inc. | 1 | $28 |
| Sandoz | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,832 in reported general payments places this provider in the 85th percentile of 67 dermatology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 30 | $112,401 |
| Tacrolimus | 68 | $18,330 |
| Pimecrolimus | 37 | $11,402 |
| Fluocinonide | 222 | $11,179 |
| Clobetasol Propionate | 157 | $10,010 |
| Halobetasol Propionate | 94 | $5,401 |
| Ciclopirox | 94 | $5,145 |
| Ketoconazole | 164 | $3,776 |
| CiclopiroxCiclopirox Olamine | 147 | $3,571 |
| Triamcinolone Acetonide | 272 | $3,492 |
| Betamethasone Dipropionate | 55 | $2,547 |
| Fluocinolone Acetonide | 50 | $2,107 |
| MethotrexateMethotrexate Sodium | 88 | $2,038 |
| Tretinoin | 22 | $1,441 |
| Clindamycin Phosphate | 31 | $1,349 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Honolulu
- Sarah HowellHonolulu$653K
- Douglas JohnsonHonolulu$568K
- Ryan SatoHonolulu$226K
- Greg SakamotoHonolulu$20K
- Kory KitagawaHonolulu$18K
- Dylan LeeHonolulu$15K
- Sarah GrekinHonolulu$13K
- Gregory HerbichHonolulu$12K
- Stella MatsudaHonolulu$9K
- Aaron FongHonolulu$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.